KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Capital Expenditures (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Capital Expenditures data on record, last reported at $177.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 3.8% year-over-year to $177.0 million; the TTM value through Dec 2025 reached $564.0 million, up 0.53%, while the annual FY2025 figure was $564.0 million, 0.53% up from the prior year.
  • Capital Expenditures reached $177.0 million in Q4 2025 per CL's latest filing, up from $155.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $221.0 million in Q4 2022 and bottomed at $107.0 million in Q1 2021.
  • Average Capital Expenditures over 5 years is $154.6 million, with a median of $158.0 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: skyrocketed 68.83% in 2021, then crashed 36.41% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $193.0 million in 2021, then increased by 14.51% to $221.0 million in 2022, then dropped by 10.86% to $197.0 million in 2023, then decreased by 6.6% to $184.0 million in 2024, then dropped by 3.8% to $177.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $177.0 million in Q4 2025, $155.0 million in Q3 2025, and $108.0 million in Q2 2025.